US Stock MarketDetailed Quotes

CG Oncology (CGON)

Watchlist
  • 54.370
  • +1.300+2.45%
Trading Jan 16 15:15 ET
4.39BMarket Cap-28.10P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CG Oncology (CGON) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
3,774.42%1.67M
0
-90.17%52K
458.33%1.14M
45,500.00%456K
377.78%43K
111K
172.68%529K
6.81%204K
1K
Operating revenue
3,774.42%1.67M
--0
-90.17%52K
458.33%1.14M
45,500.00%456K
377.78%43K
--111K
172.68%529K
6.81%204K
--1K
Cost of revenue
1.58M
0
Gross profit
106.98%89K
43K
Operating expense
80.74%51.22M
87.73%48.74M
83.74%42.26M
108.08%115.81M
98.93%38.51M
101.67%28.34M
110.64%25.96M
131.95%23M
57.05%55.65M
107.79%19.36M
Selling and administrative expenses
167.71%23.33M
132.32%17.41M
155.51%14.79M
240.40%33.7M
288.10%11.71M
276.18%8.72M
200.48%7.49M
179.21%5.79M
54.51%9.9M
82.02%3.02M
-General and administrative expense
167.71%23.33M
132.32%17.41M
155.51%14.79M
240.40%33.7M
288.10%11.71M
276.18%8.72M
200.48%7.49M
179.21%5.79M
54.51%9.9M
82.02%3.02M
Research and development costs
42.11%27.88M
69.63%31.33M
59.60%27.47M
79.45%82.1M
64.01%26.8M
67.21%19.62M
87.86%18.47M
119.46%17.21M
57.61%45.75M
113.37%16.34M
Operating profit
-80.70%-51.13M
-88.53%-48.74M
-87.83%-42.2M
-106.80%-114.67M
-96.58%-38.05M
-101.49%-28.3M
-109.74%-25.85M
-131.14%-22.47M
-57.32%-55.45M
-107.78%-19.36M
Net non-operating interest income expense
-5.97%7.42M
5.42%7.32M
39.74%7.75M
285.63%26.62M
122.72%6.25M
245.69%7.89M
800.52%6.94M
430.02%5.54M
690,500.00%6.9M
208.13%2.8M
Non-operating interest income
-5.97%7.42M
5.42%7.32M
39.74%7.75M
285.63%26.62M
122.72%6.25M
245.69%7.89M
800.52%6.94M
430.02%5.54M
--6.9M
--2.8M
Other net income (expense)
-4,900.00%-100K
-150.00%-4K
155.56%5K
104.84%3K
250.00%6K
75.00%-2K
113.79%8K
-212.50%-9K
68.37%-62K
-130.77%-4K
Other non- operating income (expenses)
-4,900.00%-100K
-150.00%-4K
155.56%5K
104.84%3K
250.00%6K
75.00%-2K
113.79%8K
-212.50%-9K
68.37%-62K
-130.77%-4K
Income before tax
-114.69%-43.81M
-119.16%-41.43M
-103.45%-34.45M
-81.12%-88.04M
-92.07%-31.8M
-73.39%-20.41M
-62.77%-18.9M
-95.38%-16.93M
-37.14%-48.61M
-97.27%-16.56M
Income tax
Net income
-114.69%-43.81M
-119.16%-41.43M
-103.45%-34.45M
-81.12%-88.04M
-92.07%-31.8M
-73.39%-20.41M
-62.77%-18.9M
-95.38%-16.93M
-37.14%-48.61M
-97.27%-16.56M
Net income continuous Operations
-114.69%-43.81M
-119.16%-41.43M
-103.45%-34.45M
-81.12%-88.04M
-92.07%-31.8M
-73.39%-20.41M
-62.77%-18.9M
-95.38%-16.93M
-37.14%-48.61M
-97.27%-16.56M
Minority interest income
Net income attributable to the parent company
-114.69%-43.81M
-119.16%-41.43M
-103.45%-34.45M
-81.12%-88.04M
-92.07%-31.8M
-73.39%-20.41M
-62.77%-18.9M
-95.38%-16.93M
-37.14%-48.61M
-97.27%-16.56M
Preferred stock dividends
129.97%19.19M
57.43%5.94M
Other preferred stock dividends
Net income attributable to common stockholders
-114.69%-43.81M
-119.16%-41.43M
-103.45%-34.45M
-29.85%-88.04M
-41.39%-31.8M
-16.51%-20.41M
-22.83%-18.9M
-36.55%-16.93M
-54.83%-67.8M
-84.92%-22.49M
Basic earnings per share
-90.00%-0.57
-92.86%-0.54
-25.00%-0.45
-32.03%-1.41
-35.49%-0.48
-8.74%-0.3
-15.51%-0.28
87.43%-0.36
90.88%-1.068
87.38%-0.3543
Diluted earnings per share
-90.00%-0.57
-92.86%-0.54
-25.00%-0.45
-32.03%-1.41
-35.49%-0.48
-8.74%-0.3
-15.51%-0.28
87.43%-0.36
90.88%-1.068
87.38%-0.3543
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 3,774.42%1.67M0-90.17%52K458.33%1.14M45,500.00%456K377.78%43K111K172.68%529K6.81%204K1K
Operating revenue 3,774.42%1.67M--0-90.17%52K458.33%1.14M45,500.00%456K377.78%43K--111K172.68%529K6.81%204K--1K
Cost of revenue 1.58M0
Gross profit 106.98%89K43K
Operating expense 80.74%51.22M87.73%48.74M83.74%42.26M108.08%115.81M98.93%38.51M101.67%28.34M110.64%25.96M131.95%23M57.05%55.65M107.79%19.36M
Selling and administrative expenses 167.71%23.33M132.32%17.41M155.51%14.79M240.40%33.7M288.10%11.71M276.18%8.72M200.48%7.49M179.21%5.79M54.51%9.9M82.02%3.02M
-General and administrative expense 167.71%23.33M132.32%17.41M155.51%14.79M240.40%33.7M288.10%11.71M276.18%8.72M200.48%7.49M179.21%5.79M54.51%9.9M82.02%3.02M
Research and development costs 42.11%27.88M69.63%31.33M59.60%27.47M79.45%82.1M64.01%26.8M67.21%19.62M87.86%18.47M119.46%17.21M57.61%45.75M113.37%16.34M
Operating profit -80.70%-51.13M-88.53%-48.74M-87.83%-42.2M-106.80%-114.67M-96.58%-38.05M-101.49%-28.3M-109.74%-25.85M-131.14%-22.47M-57.32%-55.45M-107.78%-19.36M
Net non-operating interest income expense -5.97%7.42M5.42%7.32M39.74%7.75M285.63%26.62M122.72%6.25M245.69%7.89M800.52%6.94M430.02%5.54M690,500.00%6.9M208.13%2.8M
Non-operating interest income -5.97%7.42M5.42%7.32M39.74%7.75M285.63%26.62M122.72%6.25M245.69%7.89M800.52%6.94M430.02%5.54M--6.9M--2.8M
Other net income (expense) -4,900.00%-100K-150.00%-4K155.56%5K104.84%3K250.00%6K75.00%-2K113.79%8K-212.50%-9K68.37%-62K-130.77%-4K
Other non- operating income (expenses) -4,900.00%-100K-150.00%-4K155.56%5K104.84%3K250.00%6K75.00%-2K113.79%8K-212.50%-9K68.37%-62K-130.77%-4K
Income before tax -114.69%-43.81M-119.16%-41.43M-103.45%-34.45M-81.12%-88.04M-92.07%-31.8M-73.39%-20.41M-62.77%-18.9M-95.38%-16.93M-37.14%-48.61M-97.27%-16.56M
Income tax
Net income -114.69%-43.81M-119.16%-41.43M-103.45%-34.45M-81.12%-88.04M-92.07%-31.8M-73.39%-20.41M-62.77%-18.9M-95.38%-16.93M-37.14%-48.61M-97.27%-16.56M
Net income continuous Operations -114.69%-43.81M-119.16%-41.43M-103.45%-34.45M-81.12%-88.04M-92.07%-31.8M-73.39%-20.41M-62.77%-18.9M-95.38%-16.93M-37.14%-48.61M-97.27%-16.56M
Minority interest income
Net income attributable to the parent company -114.69%-43.81M-119.16%-41.43M-103.45%-34.45M-81.12%-88.04M-92.07%-31.8M-73.39%-20.41M-62.77%-18.9M-95.38%-16.93M-37.14%-48.61M-97.27%-16.56M
Preferred stock dividends 129.97%19.19M57.43%5.94M
Other preferred stock dividends
Net income attributable to common stockholders -114.69%-43.81M-119.16%-41.43M-103.45%-34.45M-29.85%-88.04M-41.39%-31.8M-16.51%-20.41M-22.83%-18.9M-36.55%-16.93M-54.83%-67.8M-84.92%-22.49M
Basic earnings per share -90.00%-0.57-92.86%-0.54-25.00%-0.45-32.03%-1.41-35.49%-0.48-8.74%-0.3-15.51%-0.2887.43%-0.3690.88%-1.06887.38%-0.3543
Diluted earnings per share -90.00%-0.57-92.86%-0.54-25.00%-0.45-32.03%-1.41-35.49%-0.48-8.74%-0.3-15.51%-0.2887.43%-0.3690.88%-1.06887.38%-0.3543
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.08%
Sample Name
Sample Code
 +3.14%
Sample Name
Sample Code
 +2.58%
4
Tempus AI
TEM
+2.26%
5
Block
XYZ
+1.25%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.83%
Sample Name
Sample Code
 +10.43%
Sample Name
Sample Code
 +10.03%
4
Kingsoft Cloud
KC
+7.44%
5
United Microelectronics
UMC
+6.31%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -